Orbis Medicines

Science-Driven Innovation in Drug Discovery

Backed by leading life sciences investors such as Novo Holdings and Forbion, Orbis Medicines is transforming drug discovery through cutting-edge science, focusing on oral macrocycle therapeutics. Our proprietary nGen platform integrates AI and machine learning to automate the design, synthesis, and testing of macrocycle compounds. These large, flexible molecules can penetrate cells and be made orally available, addressing therapeutic targets unreachable by traditional drugs.

The nGen platform uses massive chemical libraries of over 100 billion compounds, with automated synthesis and machine learning accelerating discovery. By identifying and optimizing drug candidates at unparalleled speed, we aim to create oral alternatives to blockbuster biologics for diseases that were previously untreatable.

We are a fast-growing biotech and as a part of our team, you’ll join an agile, entrepreneurial environment where innovation and rapid decision-making are the norms. We're expanding our global presence with a new R&D hub in Copenhagen, offering a unique opportunity to work on groundbreaking projects using AI-driven technologies and cutting-edge science. In our dynamic, scale-up culture, your ideas will be heard, your contributions will directly impact our mission, and you will have the opportunity to be at the forefront of biotech innovation. Join us, and be a crucial part of bringing first-in-class, life-changing medicines to market.